Chicago Capital Management’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
Chicago Capital Management's XENT Position: Q2 2022 in Review
Chicago Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 141,111 shares — an estimated $3.95M sold.
Chicago Capital Management first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $3.95M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Chicago Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Chicago Capital Management sold 141,111 Intersect ENT, Inc shares in Q2 2022, an estimated $3.95M.
- Chicago Capital Management first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
- Chicago Capital Management's Intersect ENT, Inc position peaked at $3.95M in Q1 2022.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Chicago Capital Management's 13F filing for Q2 2022, filed 27 Jul 2022.